• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠球菌分泌组凭借其抗增殖特性和纳米封装效应抑制耐万古霉素粪肠球菌V853的生长。

The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects.

作者信息

Youssef Hadeer, Azmy Ahmed F, Eid Hussein M, Sayed Ossama M, Eldomany Ehab B, Farghali Ahmed A, Molham Fatma

机构信息

Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, Egypt.

Microbiology and Immunology Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62514, Egypt.

出版信息

Int Microbiol. 2025 Feb;28(2):227-239. doi: 10.1007/s10123-024-00534-6. Epub 2024 May 22.

DOI:10.1007/s10123-024-00534-6
PMID:38775969
Abstract

In our study, the secretome of the clinical isolate Enterococcus faecalis HY7 displayed antibacterial activity against the vancomycin-resistant Enterococcus faecalis V853. These bacteriocin-like substances showed thermal stability at a wide range of temperatures up to 121 °C, while proteinase K treatment resulted in a total loss of their activity. PCR-based screening for bacteriocin biosynthetic genes revealed that Enterococcus faecalis HY7 harbored multiple enterocin-producing genes, including ent A, avc A, and as-48. The production kinetics demonstrated the highest levels of bacteriocins production at 16 h, whereas the activity was diminished after 32 h of microbial growth. Notably, the partially purified bacteriocins exhibited anti-proliferative activity on the colon cancer cells, Caco2, with an IC50 value of 172.8 μg/mL. Remarkably, the nanoencapsulation of our bacteriocins in liposome showed a fourfold increase in its anti-vancomycin-resistant Enterococcus activity, which is the first report of liposome encapsulation with anti-vancomycin resistant Enterococcus bacteriocin.

摘要

在我们的研究中,临床分离株粪肠球菌HY7的分泌蛋白组对耐万古霉素粪肠球菌V853显示出抗菌活性。这些类细菌素物质在高达121℃的广泛温度范围内表现出热稳定性,而蛋白酶K处理导致其活性完全丧失。基于PCR的细菌素生物合成基因筛选显示,粪肠球菌HY7含有多个产肠球菌素基因,包括ent A、avc A和as-48。生产动力学表明,在16小时时细菌素产量最高,而在微生物生长32小时后活性降低。值得注意的是,部分纯化的细菌素对结肠癌细胞Caco2表现出抗增殖活性,IC50值为172.8μg/mL。值得注意的是,我们的细菌素在脂质体中的纳米包封显示其抗耐万古霉素肠球菌活性增加了四倍,这是脂质体包封抗耐万古霉素肠球菌细菌素的首次报道。

相似文献

1
The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects.肠球菌分泌组凭借其抗增殖特性和纳米封装效应抑制耐万古霉素粪肠球菌V853的生长。
Int Microbiol. 2025 Feb;28(2):227-239. doi: 10.1007/s10123-024-00534-6. Epub 2024 May 22.
2
Comprehensive analysis of bacteriocins produced by clinical enterococcal isolates and their antibacterial activity against Enterococci including VRE.临床肠球菌分离株产生的细菌素及其对包括耐万古霉素肠球菌在内的肠球菌的抗菌活性的综合分析。
Sci Rep. 2025 Feb 9;15(1):4846. doi: 10.1038/s41598-025-89518-8.
3
Purification and characterization of bacteriocins-like inhibitory substances from food isolated Enterococcus faecalis OS13 with activity against nosocomial enterococci.从食品中分离出的具有抗医院肠球菌活性的屎肠球菌 OS13 中细菌素样抑制物质的纯化和特性研究。
Sci Rep. 2021 Feb 15;11(1):3795. doi: 10.1038/s41598-021-83357-z.
4
A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci.一种来自粪肠球菌478的新型细菌素对耐万古霉素肠球菌具有强大的活性。
PLoS One. 2017 Oct 12;12(10):e0186415. doi: 10.1371/journal.pone.0186415. eCollection 2017.
5
Evaluation of the activity and molecular characterisation of bacteriocins produced by E. faecium and E. faecalis isolated from different hosts against public health-threating pathogens.对从不同宿主分离出的屎肠球菌和粪肠球菌所产生的细菌素针对威胁公共卫生的病原体的活性评估及分子特性分析。
Microb Pathog. 2025 May;202:107432. doi: 10.1016/j.micpath.2025.107432. Epub 2025 Feb 26.
6
Preliminary characterization of bacteriocins produced by Enterococcus faecium and Enterococcus faecalis isolated from pig faeces.从猪粪便中分离出的粪肠球菌和屎肠球菌所产细菌素的初步特性分析
J Appl Microbiol. 2000 Mar;88(3):482-94. doi: 10.1046/j.1365-2672.2000.00986.x.
7
Characterization of Enterococcus faecium E86 bacteriocins and their inhibition properties against Listeria monocytogenes and vancomycin-resistant Enterococcus.肠球菌 E86 细菌素的特性及其对单核细胞增生李斯特菌和耐万古霉素肠球菌的抑制特性。
Braz J Microbiol. 2021 Sep;52(3):1513-1522. doi: 10.1007/s42770-021-00494-3. Epub 2021 Apr 26.
8
Antimicrobial activity of bacteriocins produced by Enterococcus isolates recovered from Egyptian homemade dairy products against some foodborne pathogens.从埃及自制乳制品中分离出的肠球菌产生的细菌素对某些食源性病原体的抗菌活性。
Int Microbiol. 2020 Nov;23(4):533-547. doi: 10.1007/s10123-020-00127-z. Epub 2020 Apr 18.
9
A bacteriocin expression platform for targeting pathogenic bacterial species.一种用于靶向致病性细菌物种的细菌素表达平台。
Nat Commun. 2024 Jul 27;15(1):6332. doi: 10.1038/s41467-024-50591-8.
10
Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.粪肠球菌DSH20产生的一种紫外线稳定的类细菌素抑制物质(BLIS)对耐万古霉素肠球菌(VRE)菌株的抗菌活性。
J Microbiol Immunol Infect. 2014 Oct;47(5):371-6. doi: 10.1016/j.jmii.2013.05.004. Epub 2013 Jul 6.

本文引用的文献

1
Intranasal Delivery of Granisetron to the Brain via Nanostructured Cubosomes-Based In Situ Gel for Improved Management of Chemotherapy-Induced Emesis.通过基于纳米结构立方液晶的原位凝胶将格拉司琼经鼻递送至脑以改善化疗引起的呕吐的管理
Pharmaceutics. 2022 Jun 29;14(7):1374. doi: 10.3390/pharmaceutics14071374.
2
Anti-cancer and antimicrobial potential of five soil : a metabolomics-based study.五种土壤的抗癌和抗菌潜力:一项基于代谢组学的研究
R Soc Open Sci. 2022 Feb 9;9(2):211509. doi: 10.1098/rsos.211509. eCollection 2022 Feb.
3
Potential Use of Tailored Citicoline Chitosan-Coated Liposomes for Effective Wound Healing in Diabetic Rat Model.
定制胞磷胆碱壳聚糖包被脂质体在糖尿病大鼠模型中有效伤口愈合的潜在用途。
Int J Nanomedicine. 2022 Feb 5;17:555-575. doi: 10.2147/IJN.S342504. eCollection 2022.
4
Probiotic potential and safety assessment of bacteriocinogenic strains with antibacterial activity against and vancomycin-resistant enterococci.对具有抗万古霉素耐药肠球菌抗菌活性的产细菌素菌株的益生菌潜力及安全性评估
Curr Res Microb Sci. 2021 Aug 30;2:100070. doi: 10.1016/j.crmicr.2021.100070. eCollection 2021 Dec.
5
spp. as a Producer and Target of Bacteriocins: A Double-Edged Sword in the Antimicrobial Resistance Crisis Context.作为细菌素的生产者和靶标的物种:抗菌药物耐药性危机背景下的双刃剑
Antibiotics (Basel). 2021 Oct 7;10(10):1215. doi: 10.3390/antibiotics10101215.
6
The microbiome-shaping roles of bacteriocins.细菌素在微生物组形成中的作用。
Nat Rev Microbiol. 2021 Nov;19(11):726-739. doi: 10.1038/s41579-021-00569-w. Epub 2021 Jun 1.
7
Characterization of Partially Purified Bacteriocins Produced by Strains Isolated from Soybean Paste Active Against spp. and Vancomycin-Resistant Enterococci.从豆瓣酱中分离出的对[具体菌名]和耐万古霉素肠球菌具有活性的菌株所产生的部分纯化细菌素的特性分析
Microorganisms. 2021 May 18;9(5):1085. doi: 10.3390/microorganisms9051085.
8
MEGA11: Molecular Evolutionary Genetics Analysis Version 11.MEGA11:分子进化遗传学分析版本 11。
Mol Biol Evol. 2021 Jun 25;38(7):3022-3027. doi: 10.1093/molbev/msab120.
9
Exploring the Therapeutic Potenital of the Leaderless Enterocins K1 and EJ97 in the Treatment of Vancomycin-Resistant Enterococcal Infection.探索无乳链球菌肠毒素K1和EJ97在治疗耐万古霉素肠球菌感染中的治疗潜力。
Front Microbiol. 2021 Feb 17;12:649339. doi: 10.3389/fmicb.2021.649339. eCollection 2021.
10
Antilisterial Activity of Bacteriocins Produced by Lactic Bacteria Isolated from Dairy Products.从乳制品中分离的乳酸菌产生的细菌素的抗李斯特菌活性
Foods. 2020 Nov 27;9(12):1757. doi: 10.3390/foods9121757.